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Abstract
With the advancement in imaging technology and pathological evaluation, several 
unusual adrenal gland lesions have been identified over the years. Presently, the liter-
ature consists of case reports or small case series without a comprehensive review on 
these uncommon adrenal pathologies. The current chapter discusses the epidemiology, 
pathogenesis, pathology, imaging features and management principles of uncommonly 
reported infectious and neoplastic adrenal masses.
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1. Introduction
The diagnosis of unusual adrenal gland masses over the past years has been facilitated by 
advances in imaging and molecular histopathology. This chapter of unusual adrenal masses 
as a result of infection, benign or malignant tumors provides the most comprehensive review 
and recent information on this topic. The epidemiology, clinical presentation, radiologic and 
pathologic features of atypical adrenal masses as well as their current management will be 
discussed.
2. Infections presenting as adrenal masses
The adrenal gland can be infected by several pathogens including bacteria, fungi, viruses and 
parasites. Infections of the adrenal gland are important, but an underreported clinical entity. 
Such infections can cause either direct adrenal tissue damage during microbial replication and 
toxin production or indirect damage through alteration of host’s immunologic and endocrine 
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response to an infection from a distant site. Disparities in pathogen tropism, adrenal anatomy, 
and host immune integrity contribute to active disease progression and adrenal dysfunction. 
Timely diagnosis and management of such adrenal infections significantly improves outcome, 
thereby highlighting the importance of clinical suspicion in the clinic setting [1].
2.1. Adrenal tuberculosis
In one reported series, the incidence of adrenal involvement was 6% of patients with active 
tuberculosis [2]. Adrenal glands are infected through a hematogenous route [3]. Clinical 
manifestations may take years to appear while others may have asymptomatic infections. 
Tuberculosis must be suspected in patients with a fever along with adrenomegaly [4]. At least 
90% of the adrenal gland must be involved with parenchymal destruction before clinical fea-
tures of adrenal insufficiency appear [5]. Stress and inflammation are thought to be underly-
ing reasons for adrenal enlargement in patients with tuberculosis without microbial seeding 
of the glands. While few studies have demonstrated elevated basal and stimulated cortisol 
levels [6], others have shown lower cortisol levels [7].
Imaging studies help in the evaluation of affected adrenal glands (Figure 1). Most patients with 
active or recently acquired disease (within 2 years) have bilateral adrenal enlargement, while the 
remaining with remote infection or inactive disease have calcifications and/or gland atrophy [5, 
8]. In one study, 91% of patients with adrenal tuberculosis who underwent CT had bilaterally 
enlarged adrenal glands, while 2% had normal sized glands. Among those with adrenal enlarge-
ment, mass-like lesions were noted in 49% while enlargement with preserved contours was found 
in the remaining 51% of patients; more than half of them had peripheral rim enhancement. With 
longer duration of disease, calcifications and contour preservation were seen more frequently, 
whereas peripheral rim enhancement and mass-like enlargement seen less significantly on CT 
images [9]. Adrenal glands may also be enlarged in patients with extra-adrenal tuberculosis. 
Although not needed in cases of extra-adrenal tuberculosis, an adrenal biopsy may be diagnostic 
in patients with suspected adrenal tuberculosis without extra-adrenal disease [3, 10].
Treatment includes multiple antituberculosis medications. Studies have demonstrated reduc-
tion of gland size after successful treatment of extra-adrenal tuberculosis [11]. In patients with 
adrenal insufficiency, antituberculosis medications do not effectively restore adrenal function 
after treatment. Furthermore, steroid replacement therapy may need to be increased as rifam-
picin induces glucocorticoid metabolism in the liver [12].
2.2. Adrenal histoplasmosis
Adrenal involvement is usually found in patients with disseminated histoplasmosis. The clin-
ical, pathologic and radiologic presentation is similar to that of tuberculosis with diagnosis 
confirmed by adrenal gland biopsy [13, 14]. In one series, primary adrenal insufficiency was 
reported in 41% of patients [15]. Populations at risk for adrenal histoplasmosis include immu-
nocompromised, posttransplant and elderly patients [16]. CT usually demonstrates bilaterally 
enlarged adrenal glands, whereas pathologic examination reveals necrotizing granulomas 
and caseous necrosis. Differential diagnosis of bilateral adrenomegaly includes lymphoma, 
metastasis, sarcoidosis, adrenal hemorrhage, and infections like tuberculosis, histoplasmosis, 
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cryptococcosis, coccidioidomycosis and blastomycosis. However, central hypodensity and 
peripheral rim enhancement of the adrenal glands by CT narrows the differential diagno-
sis to histoplasmosis and tuberculosis only [17]. Recommended antifungal therapy includes 
amphotericin B followed by itraconazole (for disseminated disease), and glucocorticoid and 
mineralocorticoid replacement for adrenal insufficiency.
2.3. Adrenal cryptococcosis
Cryptococcal infections most commonly present as pneumonia or meningitis with adrenal 
glands only usually involved in immunocompromised patients with disseminated cryptococ-
cal infection [18]. However, cases of isolated adrenal gland involvement have been reported 
[19]. CT can demonstrate enlarged adrenal glands [20], and diagnosis is confirmed by a biopsy 
that shows budding yeasts with capsules on smear examination with India ink or methenamine 
silver stain (Figure 2). In most cases, cryptococcal antigen titers are elevated and used as a 
biomarker for disease resolution [21]. Intensive Amphotericin B therapy followed by oral flu-
conazole consolidation (usually 6-month course) is an effective multidrug treatment regimen 
Figure 1. Radiological features of adrenal tuberculosis. (a) Adrenal enlargement with high contrast uptake and rim 
enhancement demonstrated on CT scan; (b) Adrenal enlargement shown on a coronal FS T1 MRI scan; (c) Adrenal 
enlargement shown on an axial FS T1 MRI scan; (d) Significant reduction of the volume of the adrenal glands with no 
pathological contrast uptake on a CT scan after treatment. (Courtesy: Ref. [4].)
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[22, 23]. In contrast to adrenal tuberculosis and histoplasmosis, adrenal insufficiency is often 
improved with resolution of this infection. Adrenal cryptococcal infection resistant to antifun-
gal therapy may respond to adrenalectomy [24].
3. Parasitic infections of the adrenal glands
Parasitic infections of the adrenal glands are rarely reported, and their prevalence depends on 
the organism, residence in endemic areas and host immune integrity [1]. The nature of adrenal 
gland involvement varies significantly depending on the microbe. Case reports have shown 
adrenal involvement with a wide range of pathogens that includes Echinococcus, Leishmania, 
Trypanosoma, Microsporidia and amebic species.
3.1. Adrenal echinococcosis
Echinococcal infections of the adrenal glands are uncommon, accounting for 6–7% of all cysts 
[25–27]. Adrenal involvement is usually secondary, and part of generalized echinococcosis [25, 
28]. Most cases are discovered incidentally, although some cases present with nonspecific dull 
aching flank pain [29]. Adrenal hydatids can cause hypertension, known as “the Goldblatt phe-
nomenon”, due to irritation of functional tissue of the adrenal gland by the growing cyst [30].
Imaging studies are helpful in characterizing infected adrenal cysts, and ultrasonography (US) 
is particularly helpful in securing the diagnosis. US of the adrenal cyst can demonstrate loca-
tion, size and number along with cyst features that include floating membranes, daughter 
cysts, multiple septa and hydatids. The WHO/IWG-E classification for diagnosis and treatment 
Figure 2. Microscopic examination of cryptococcal infection. Methenamine silver stain shows the yeast, some of which 
demonstrate budding (40x). (Courtesy: Ref. [22].)
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of echinococcal cysts is based on US imaging characteristics that classify cysts into six subtypes 
(CL, CE1 to CE5) and three relevant groups: active (CE1 and 2), transitional (CE3) and inactive 
(CE4 and 5) [31]. On CT, unilocular or multilocular cysts are identified with debris, calcified 
walls, small daughter cysts and increased tissue density of hydatid membrane, which shows 
contrast enhancement [32]. CT provides information regarding the cyst number, origin and 
residual parenchyma of the affected organ, and relationship of the cyst with adjacent struc-
tures. Serological tests are marred by low sensitivity and specificity. Latest immunodiagnos-
tic tests detect echinococcal antigens in hydatid fluid fraction. These tests detect Echinococcus 
granulosus antigen 5, E. granulosus antigen B (AgB), and EpC1. AgB8/2 antigen has shown 
maximum diagnostic sensitivity (84–93%) and specificity (98–99%) [33, 34]. Serology is helpful 
in continued patient monitoring as titers decrease following definitive therapy [35].
Multiple therapeutic options include medical therapy, percutaneous intervention, open and 
minimally invasive laparoscopic and robotic surgeries. Surgical excision usually results in 
definitive cure. Medical therapy is usually implemented as an adjunct to surgical excision. 
Antiparasitic medications as primary treatment is recommended for cases with dissemi-
nated hydatidosis, brain or bony echinococcosis or in patients with poor surgical risk [32]. 
Preoperative oral therapy with albendazole (10–15 mg/kg per day) with or without praziqu-
antel (50 mg/kg) for 4 weeks before surgery may kill scolices, make the cyst inactive, decrease 
cyst material antigenicity, reduce cyst wall tension and thereby reduce the risk of spillage 
[26]. In liver echinococcosis, studies have shown a lower risk of recurrence following surgery 
in cases that had received preoperative albendazole versus those who did not (4 vs. 19%), 
respectively [36]. Limitations of medical therapy include serious drug-related adverse effects 
such as leukopenia, hepatotoxicity, allergic reactions and alopecia [37], and limited experi-
ence in its use in genitourinary echinococcosis.
Surgical management involves adrenal hydatid cyst excision by laparoscopic or open tech-
niques [29]. It is difficult to determine whether complete excision of adrenal is mandatory as 
data is limited. In a series of nine cases, adrenalectomy was performed in patients with adrenal 
cysts with no recurrence at a median follow-up of 16 months (range: 6–64 months) [25]. In 
another study, transperitoneal laparoscopic aspiration with instillation of scolicidal agent with 
partial cystectomy for an adrenal hydatid cyst was performed (Figure 3). The cyst densely 
adhered to the renal vessels and complete excision involved risk of nephrectomy. Betadine 
soaked gauze pieces were packed around the cyst. The cyst was aspirated followed by instil-
lation of scolicidal agent that was maintained for 10 min. A 10-mm trocar was introduced into 
the cyst, and its contents, including the germinal layer, were suctioned and followed by partial 
cyst wall excision. No recurrence was noted at 6-months follow-up. The authors concluded 
that total adrenal gland excision may be needed only in cases with complete gland destruction 
[38]. Complete evacuation of cyst contents and prevention of viable scolices spillage intraperi-
toneally remains a key principle in the management of adrenal hydatid cysts.
3.2. Other adrenal infections presenting as cysts/masses
Visceral leishmaniasis can present with cystic adrenal disease in both immunocompetent and 
immunocompromised individuals [39, 40]. Rarely, amebic species have been found in cystic 
lesions of the adrenal gland [1]. Trypanosoma cruzi, the causative agent of Chagas disease, has 
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been found in infected adrenal glands, which may serve as a reservoir. Investigators have 
found a correlation between central vein infection of the adrenal gland and development 
of chagasic myocarditis [41]. African trypanosomiasis has been found to be associated with 
polyendocrinopathies including hypothyroidism, hypogonadism and adrenal insufficiency 
resulting from either primary gland or secondary (central) involvement. In a series of 137 
patients, adrenal and thyroid function recovered with medical treatment, but hypogonad-
ism tended to persist for years [42]. Two drugs, benznidazole, and nifurtimox are available 
for treatment of T. cruzi infection. However, both benznidazole and nifurtimox are limited in 
their capacity to provide a parasitologic cure, especially in chronically infected patients [43]. 
Adrenal involvement from disseminated microsporidia in immunocompromised patients 
induces large necrotic lesions with histiocytic and fibrotic reactions within the gland sub-
strate [44].
HIV infection affects the adrenal gland in several ways. Apart from direct infection, opportu-
nistic infections and antiretroviral medications also have a significant effect on adrenal glands 
that can lead to adrenal insufficiency. Cases with HIV infection can harbor adrenal tumors 
like Kaposi’s sarcoma secondary to co-infection with oncogenic human herpesvirus type 8 
(HHV8), and non-Hodgkin’s lymphoma (high-grade malignant B phenotype) secondary to 
Epstein-Barr virus (EBV) infection [45, 46].
4. Adrenal tumors
This section describes uncommon benign and malignant adrenal tumors and current concepts 
in their management.
4.1. Adrenal leiomyoma
Leiomyoma of the adrenal glands is extremely rare tumors with less than 20 cases reported 
in the literature [47]. Although benign tumors, they may mimic malignant adrenal tumors on 
Figure 3. Laparoscopic management of adrenal hydatid cysts. Intraoperative photograph showing cyst aspiration by 
directly inserting a trocar into the cyst and laparoscopic cyst dissection after aspiration. (Courtesy: Ref. [38].)
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radiologic imaging. Age at presentation in patients ranges from 2 to 72 years with 61% usu-
ally occurring in women. Tumor size varies from 3 to 11 cm in diameter [48]. Usually asymp-
tomatic and nonfunctional, such tumors present as adrenal incidentalomas and occasionally 
as calcified masses [49]. Some patients may present with vague, nonspecific flank or upper 
abdominal pain. Many cases of adrenal leiomyomas have been reported to occur in patients 
with acquired immune deficiency syndrome (AIDS), or latent Epstein-Barr infection [48, 50]. 
Associated smooth-muscle tumors and Kaposi’s sarcoma may arise from a common stem cell 
under the influence of some unknown factor produced during HIV infection [51]. Grossly, cut 
sections often demonstrate a whorled appearance. Light microscopy shows spindle-shaped 
cells arranged in fascicles and whorls (Figure 4) [47]. Immunohistochemistry helps in estab-
lishing a diagnosis as the tumor cells show diffuse and strong positivity for smooth muscle 
actin [52]. Prognosis is good following complete surgical resection. With the advent of mini-
mally invasive surgery, laparoscopic resection is feasible with good perioperative outcomes 
[49]. Large tumors, however, do pose challenges for adjacent vital organ preservation during 
surgical resection.
4.2. Inflammatory myofibroblastic tumor (IMT)
Inflammatory myofibroblastic tumor (IMT) was first described in 1939. Previously known as 
plasma cell granuloma or inflammatory pseudotumor, the term “inflammatory myofibroblas-
tic tumor” was introduced in 1986 [53–55]. Although found in the adrenal glands, the most 
common site of IMT is the lung followed by the orbit [55].
Cytogenetic and molecular advancements have confirmed the neoplastic nature of IMT and 
their recurrence potential [56, 57]. They exhibit cytogenetic clonality, the involvement of chro-
mosomal region 2p23, occasional aggressive local behavior, and metastasis described in most 
locations, in both sexes and at all ages [58, 59]. Mean tumor size at the time of presentation 
ranges from 5 to 10 cm. IMT usually present as an adrenal incidentaloma, although 10–20% of 
Figure 4. Histopathologic images of adrenal leiomyoma. (A) Normal adrenal gland seen at the periphery with 
encapsulated tumor arranged in long and short fascicles (H&E, ×40). (B) Higher magnification showing fascicles of 
benign spindle-shaped cells with minimal nuclear atypia (H&E, × 200). (C) Neoplastic cells showing strong positivity 
with smooth muscle actin (immunoperoxidase, ×200). (Courtesy: Ref. [49].)
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patients have a fever, weight loss or flank pain [60]. These lesions do not demonstrate specific 
imaging features [60]. Enhanced CT may show heterogeneity or homogeneity of a hypo-, iso- 
or hyperdense adrenal mass [61].
Grossly, IMT appears firm, fleshy or gelatinous with a white or tan cut surface. Few may 
also demonstrate calcification, hemorrhage, and necrosis [59]. Histopathology reveals plump 
fibroblast or myofibroblast proliferation along with prominent infiltrate of chronic inflam-
matory cells, especially plasma cells. The presence of these plasma cells helps distinguish 
these adrenal tumors from fibromatosis and fasciitis. The epithelioid variant of IMT is rare 
with an aggressive clinical course [62]. Histologic markers of aggressive behavior include the 
presence of ganglion-like cells, cellular atypia, aneuploidy, and p53 overexpression [63]. On 
immunohistochemistry, these adrenal tumors usually express actin with occasional positivity 
for desmin and keratin. Thirty to 40% of tumors have ALK protein overexpression as a result 
of ALK gene rearrangement. Clinical correlation has shown that most patients with tumor 
metastasis were negative for ALK overexpression [64].
Complete surgical resection is essential since malignancy cannot be excluded preoperatively. 
Ten to 25% of patients have been reported to have a local recurrence following complete 
surgical excision. These tumors are considered to be low-grade sarcomas with less than 5% 
incidence of metastasis. Nevertheless, their biological behavior cannot be predicted based on 
their morphologic appearance [60].
4.3. Primitive neuroectodermal tumors (PNETs)
Primitive neuroectodermal tumors (PNETs) are associated with a family of small round 
cell tumors. Initially described a century ago by Arthur Stout in a 42-year male with an ulnar 
nerve tumor, it was not until 1973 when Hart and Earle coined the term “primitive neuroecto-
dermal tumor” for such unspecialized small round cell tumors [65, 66]. PNETs are classified as 
central (arising from the central nervous system) and peripheral [67]. Peripheral PNETs that 
arise from the adrenal glands are extremely rare with less than two-dozen cases reported in the 
literature. They usually present as a large (>10 cm), nonfunctioning adrenal mass often associ-
ated with abdominal pain and metastasis. These solid and/or cystic lesions can rapidly grow 
and are difficult to differentiate from adrenocortical carcinoma (ACC) radiologically [67, 68]. CT 
can show irregular bordered, diffusively growing, and unevenly enhancing adrenal masses [67].
Both PNETs and Ewing’s sarcoma share a unique translocation “t(11;22)(q24q12): fusion gene 
designated EWS/FLI-1” [69]. FLI-1 is a member of ETS family of transcription factors [69]. 
Microscopic examination along with immunohistochemistry helps establish the diagnosis. 
On light microscopy, classic features include small round cell tumors arranged in nests/
rosettes (Figure 5). These cells have little endoplasm with dark stained nucleus high in nucleo-
plasm [67]. Among all the markers, Mic-2 (CD-99) is the most sensitive and specific marker 
(nearly 100%), which is a cell surface glycoprotein coded by genes on X and Y-chromosomes 
[70]. Other common markers of neural differentiation include neuron-specific enolase (NSE), 
S-100 protein, neurofilaments, synaptophysin (Syn), chromogranin A (CgA) and vimentin. 
The most reliable findings for pathologic diagnosis of PNETs are the existence of rosettes, and 
two or more positive results of the aforementioned neural markers [67, 71–73].
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Since adrenal PNETs are an uncommon clinical entity, an effective treatment protocol is not yet 
established. Surgical excision remains the mainstay for local disease control. Adrenalectomy 
is usually followed by adjuvant radiochemotherapy [74]. A recommended regimen is the 
alternating use of CAV (cyclophosphamide: CTX; adriamycin: ADM; and vincristine: VCR), 
and IE (ifosfamide: IFO; and etoposide: ETO) protocols as PNET rapidly develop resistance to 
a particular regimen [75]. In general, 5-year survival of patients with PNETs is 58–61% with a 
median survival of 120 months. Local or distant metastasis at the time of diagnosis is associ-
ated with poor outcome [70].
4.4. Adrenal oncocytoma
Adrenal oncocytomas are rare tumors. Although considered benign and nonfunctional, 
these adrenal masses are malignant in 20% and hormonally active in 10–20% of patients [76]. 
Adrenal oncocytomas have been described in a wide age group (27–72 years) and usually 
discovered as incidentalomas [77]. Women are more commonly affected [78] with a predomi-
nance of the left adrenal gland (3.5:1) [79].
Such adrenal tumors are classified as either benign, borderline malignant potential or malig-
nant using the Lin-Weiss-Bisceglia system that includes the major criteria of high mitotic rate 
> 5 per 50 HPF, atypical mitoses, venous invasion; and minor criteria that include large size 
and weight, necrosis, capsular invasion, sinusoidal invasion [80]. The presence of one major 
criterion indicates malignancy, and one to four minor criteria indicates uncertain malignant 
potential. The absence of all major and minor criteria indicates a benign adrenal tumor.
Microscopically, tumor cells have abundant eosinophilic granular cytoplasm due to the accu-
mulation of mitochondria with a central pyknotic nucleus [81]. They may be arranged in 
trabecular, tubular, papillary or solid patterns. The classic central stellate scar of renal oncocy-
toma may not be seen. Immunophenotyping, in general, reveals diffuse positivity for vimen-
tin, melan-A, synaptophysin and alpha-inhibin [82].
Figure 5. Microscopic picture of adrenal primitive neuroectodermal tumor. (A) Hematoxylin and eosin stains for adrenal 
primitive neuroectodermal tumor (20×). (B) CD99 Immunohistochemical stains for adrenal primitive neuroectodermal 
tumor (20×). (Courtesy: Ref. [67].)
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Due to its large size and lack of characteristic preoperative imaging features for benignity, 
surgical resection remains the principal management for adrenal oncocytomas [79]. Surgical 
excision is a challenging task in giant adrenal oncocytomas (Figure 6). Although not infiltrat-
ing, the large size of these tumors can alter the orientation and position of adjacent viscera 
and major blood vessels. En bloc mobilization of spleen, stomach, and pancreas helps provide 
optimum exposure for large left-sided adrenal oncocytomas [83].
4.5. Adrenal myelolipoma
First described in 1905, adrenal myelolipoma is a rare adrenal tumor with a prevalence of 
<1% in autopsy series [84]. These adrenal tumors have an overall incidence of 0.05–0.2%, and 
account for about 2.5–5% of all adrenal incidentalomas. Both women and men are equally 
affected, and they are usually unilateral and rarely arise from extra-adrenal sites such as the 
retroperitoneum, thorax, and pelvis [85]. Symptomatic patients may present with abdomi-
nal pain or uncommonly with massive hemorrhage and shock, or with fever and abscess 
[85]. Tumor size varies widely from a few centimeters to >30 cm [84]. Although the tumor 
is metabolically inactive, there is a 10% incidence of associated endocrine disorders such as 
Cushing’s and Conn’s syndromes, congenital adrenal hyperplasia and diabetes [86].
These adrenal lesions are also rarely associated with thalassemia and sickle cell anemia [87, 
88]. For reasons not yet understood, myelolipomas in patients with thalassemia are usu-
ally giant and bilateral. Such association might be due to excess erythropoietin production 
[89]. Various mechanisms have been proposed regarding its pathogenesis. These tumors are 
Figure 6. CT in preoperative planning in case of giant adrenal oncocytoma. Coronal section of contrast enhanced CT 
demonstrating a giant left adrenal oncocytoma with left kidney lying in transverse plane at iliac crest. The left renal 
vessels are stretched over the inferolateral aspect of the adrenal mass. CT-angiography shows multiple feeding vessels 
to the tumor.
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believed to arise from metaplasia of reticuloendothelial cells of blood capillaries within the 
adrenal glands in response to inflammation, necrosis, infection, or stress [84]. Studies have 
shown nonrandom X-chromosome inactivation in hematopoietic lineage and fat cells, and 
balanced translocations between 3q25 and 21p11 suggestive of clonal origin [90, 91]. Tumor 
tissue consists of an admixture of mature adipose tissue, normal trilineage hematopoietic ele-
ments, and an overabundance of megakaryocytes. Unlike normal bone marrow, their cellular-
ity varies widely that does not decrease with advanced age. These lesions do not contribute 
to hematopoietic cells in circulation due to stromal irregularities and lack of capillary venous 
sinuses [90]. In most cases, this diagnosis can be made accurately on cross-sectional imaging. 
CT demonstrates a well-circumscribed lesion with a variable amount of mature adipose tissue 
with low attenuation value (around-30 Hounsfield units) with higher density myeloid com-
ponent that enhances on contrast administration (Figure 7). Nearly one-fourth of cases have 
calcifications while many have hemorrhagic areas [85]. Rare differential diagnoses include 
adrenal lipomas, teratomas, liposarcomas, metastasis and upper polar renal angiomyoli-
poma. Percutaneous biopsy may be helpful when the diagnosis is in doubt [92].
Surgical resection is the mainstay of definitive treatment; however, it is reserved for symp-
tomatic or large adrenal myelolipomas. Small and asymptomatic adrenal lesions can be fol-
lowed as they remain stable or even decrease in size over long periods of time [92]. In one 
study, the calculated doubling time of adrenal myelolipomas ranged from 4.6 to 95.1 months 
(mean 31.9 months) that confirmed the relatively slow growing nature of these tumors [93]. 
Spontaneous rupture of these lesions is a rare event and usually, occurs in lesions > 10 cm [94].
4.6. Adrenal schwannoma
Schwannomas are benign, well-encapsulated tumors arising from the nerve sheaths of cranial 
and peripheral nerves [95]. Initially described by Verocay and later subclassified by Antonini 
Figure 7. Adrenal myelolipoma. (A) Enhanced CT abdomen showing a 35 × 19 cm right suprarenal mass with areas 
of macroscopic fat densities (−19 HU) along with focal areas of enhancement. (B) Histopathology showing mature 
adipocytes admixed with hematopoietic cells suggestive of myelolipoma.
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in 1920, they account for 1–5% of all retroperitoneal tumors [96, 97]. Adrenal schwannomas 
are very rare and restricted to a few case reports. In the adrenal glands, these tumors are 
believed to arise from Schwann cells surrounding the nerves innervating the adrenal medulla 
[98]. They may present either as incidentalomas or with abdominal pain. Nonfunctional by 
nature, positive biochemical evaluation of an adrenal incidentaloma excludes the diagnosis 
of a schwannoma [96]. CT scan reveals a well-circumscribed, homogeneous, round-oval mass 
with calcification or cystic degeneration [99]. MRI findings are nonspecific and demonstrate 
solid tumors with low signal intensity on T1WI and heterogeneously high intensity on T2WI 
[100]. 18FDG–PET is helpful in differentiating benign from malignant adrenal masses based 
on standardized uptake value (SUV) [101].
Treatment of choice for adrenal schwannomas is complete surgical excision. Histologic exami-
nation reveals characteristic Antoni α and Antoni β areas seen under the microscope, and also 
nuclear free zones known as Verocay bodies that confirm the diagnosis of Schwannoma. The role 
of immunohistochemical markers including S-100 and vimentin cannot be overlooked as they 
are used for final confirmation in addition to the typical pattern described above [97, 98]. They 
also stain positive for laminin and collagen IV, and negative for desmin, keratin, actin, CD34 and 
CD117 [97]. A positive stain for calretinin is helpful in differentiating Schwannoma from neurofi-
broma [102]. Although prognosis is usually good following complete surgical resection, the pos-
sibility of local recurrence and malignant formation in benign Schwannomas does remain [103].
4.7. Adrenal ganglioneuroma
Adrenal ganglioneuromas are extremely rare benign neuroectodermal tumors composed of gan-
glion and Schwann cells [104]. These tumors are predominantly found in younger populations 
with 50% of patients between 10 and 29 years of age [104]. Although benign, isolated case reports 
of ganglioneuroma undergoing malignant transformation, cases of peripheral nerve sheath 
tumors arising within ganglioneuromas, and composite tumors of ganglioneuroma with pheo-
chromocytoma have been reported in the literature [104, 105]. Most ganglioneuromas are asymp-
tomatic, however, some patients with these tumors may present with diarrhea as they have been 
reported to secrete vasoactive intestinal polypeptide (VIP) [104, 105]. These tumors can grow to 
large size with blood vessel encasement without compromising the vascular lumen [105]. The 
biologic and radiologic features that should raise the suspicion of ganglioneuroma include: no 
adrenal hormone hyperactivity; presence of punctuate calcifications, no vascular involvement, 
nonenhanced CT attenuation of <40 Hounsfield units (HU); a homogeneous, hypointense mass 
on T1-weighted MRI; heterogeneous, hyperintense adrenal mass on T2-weighted MRI; and poor, 
delayed enhancement on dynamic MRI [106]. Histopathology reveals mature ganglion cells and 
Schwann cells among a fibrous stroma. Complete surgical resection of these adrenal masses is 
the treatment of choice. Although adrenal ganglioneuromas may encase major vessels at the time 
of surgery, organ preservation is feasible, as these tumors do not infiltrate them [107].
4.8. Adrenal lipoma
Adrenal lipomas are rare adrenal masses with the majority predominantly occurring in men 
with a range from 35 to 78 years of age [108]. These lesions account for 0.7% of all lipomatous 
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adrenal tumors [109]. These tumors are more common on the right side with a size rang-
ing from 1 to 20 cm [110]. Although usually asymptomatic, patients with larger tumors may 
experience abdominal pain whereas few patients may present with an acute abdomen due to 
retroperitoneal bleeding [111], and a smaller minority with hypertension [112]. These adrenal 
masses are thought to arise from metaplasia of either stromal or adrenal cortical cells [113]. 
CT demonstrates a well-defined adrenal lesion with fat densities without enhancing hema-
topoietic tissue as seen in myelolipomas. Microscopic examination reveals well-demarcated 
lesions composed of mature adipose lobules with occasional focal areas of calcification due to 
degenerative changes [113]. Surgical excision is curative. Although the laparoscopic approach 
is preferred, it is difficult to perform in giant adrenal lipomas and those complicated by rup-
ture, bleeding or sarcomatous changes [114].
4.9. Cystic pheochromocytoma
Cystic pheochromocytomas are rare adrenal masses thought to arise as a result of bleed-
ing, necrosis, and liquefaction within solid pheochromocytomas. Patients with such adrenal 
lesions are more likely to be asymptomatic with occasional nonspecific abdominal symptoms 
and may have a normal biochemical profile when compared to solid tumors [115, 116]. CT 
often reveals a thick walled cystic lesion with presence or absence of septa within the adrenal 
mass, and persistent wall enhancement after contrast administration [115]. Surgical excision 
is the most definitive treatment of pheochromocytomas regardless of whether the tumor is 
cystic or not [117]. It is essential to consider this diagnosis in the differential as normotensive 
patients with unsuspected cystic pheochromocytoma have been reported to have intraopera-
tive hypertensive crises during surgical excision [118].
4.10. Adrenal plasmacytoma (extramedullary plasmacytoma)
Extramedullary plasmacytoma (EMP) is defined as an extraosseous proliferation of neoplastic 
plasma cells. These adrenal tumors are cytogenetically identical to plasma cell myeloma but 
occur as isolated lesions [119]. Solitary EMP of the adrenal glands is extremely rare with fewer 
than a dozen cases reported in the literature. These adrenal masses usually occur in men than 
women (3:1) within the age range of 50–60 years [120]. The most common site of solitary EMP 
is the head and neck region followed by the gastrointestinal tract [121]. Although plasma cell 
proliferation caused by trauma might ultimately lead to clonal cell infiltration, pathogenesis 
of such tumors remains unclear [122]. Preoperative imaging of these lesions has heteroge-
neous hyperintensity on T2-weighted images.
Definitive diagnosis of adrenal plasmacytoma is based on the pathologic confirmation of 
a solitary plasma cell tumor, with or without a monoclonal gammopathy, and the absence 
of plasma cell myeloma on bone marrow biopsy [119]. Pathologic examination reveals 
dense and diffuse infiltrate of atypical plasma cells with very few admixed lymphocytes. 
Immunohistochemistry shows monoclonal immunoglobulin light chain expression. The diag-
nosis of solitary EMP can be confirmed after excluding systemic disease by serum and urine 
protein electrophoresis, immunoelectrophoresis, skeletal imaging survey, and bone marrow 
biopsy. Staging bone marrow biopsy is essential to exclude plasma cell myeloma [121].
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A standard treatment protocol has not been established for adrenal EMP. In cases with soli-
tary lesions, complete surgical resection with or without radiotherapy has been reported with 
good outcomes in term of disease-free status [122–124]. In one report, bilateral adrenal EMP 
was treated by chemotherapy and autologous hematopoietic stem cell transplantation with 
no recurrence at 47 months follow-up [125].
4.11. Non-Hodgkin lymphoma (NHL) of adrenal glands
Primary adrenal lymphoma is defined as a malignant neoplastic proliferation of lymphoid 
cells exclusively within the adrenal tissue. The adrenal glands are involved in up to 24% of 
patients with disseminated lymphoma [126]. Isolated primary adrenal lymphoma is rare, and 
constitutes 3% of extranodal lymphoma [127]. Bilateral adrenal involvement is reported in 
70% of patients [128]. Most cases are found in the elderly with a male to female ratio of 2:1. The 
most common subtype found in the adrenal glands is diffuse large B-cell lymphoma [126]. 
Multi-agent chemotherapy that includes cyclophosphamide, hydroxyl-doxorubicin (adriamy-
cin), vincristine (oncovin), and prednisolone (CHOP) along with rituximab for CD20 positive 
cases represents the cornerstone of management [129]. When an isolated adrenal mass, diag-
nosis is usually made following adrenalectomy. However, adjuvant chemotherapy is given to 
prevent disease recurrence [126]. Prognostic factors that include age, elevated serum lactate 
dehydrogenase, adrenal insufficiency and tumor size may have a significant impact on treat-
ment outcome and survival. Prognosis for patients has slightly improved with recent chemo-
therapeutic agents. Although a median survival of nearly 3 months was previously reported 
[130], most recent data in the literature suggests disease free status of 12 months [126].
4.12. Adrenal hemangioma
Adrenal hemangiomas are rare benign tumors. These lesions arise from the endothelial cell 
lining of blood vessels. Adrenal hemangiomas are believed to be congenital in origin with 
enlargement of >10 cm at the time of presentation as a result of vascular ectasia [131]. They are 
usually detected in 6 to 7th decade of life. Women are twice more commonly affected than men, 
and most cases occur unilaterally [132]. Patients are usually asymptomatic, although sponta-
neous life-threatening hemorrhage from adrenal hemangiomas has been reported [133]. Cases 
of bilateral adrenal hemangioma can also occur [134]. CT reveals heterogeneous, hypodense 
lesions with a high-density rim of tissue at the periphery [131]. Contrast-enhanced CT scans 
show peripheral spotty contrast with centripetal enhancement; this enhancement pattern is 
pathognomonic for hemangiomas. Certain patterns of calcification have also been reported, 
and include either speckled calcifications throughout the lesion or centrally located calcifica-
tions with an irregular, stellate branching pattern [135]. MRI reveals marked hyperintensity 
on T2-weighted images and focal hyperintensity on T1-weighted images with focal areas of 
hemorrhage [136]. Pathologic examination reveals multiple dilated vascular channels lined 
by single layer of endothelium with areas of hemorrhage, necrosis, and calcification [131]. 
Tumor size and symptoms help determine the need for surgical intervention in patients where 
characteristic imaging features make the diagnosis of adrenal hemangioma; lesions < 3.5 cm 
can be safely observed by serial imaging studies [137]. Surgical excision is recommended for 
larger lesions, symptomatic patients or in those patients where imaging features are atypical.
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5. Surgical excision of giant adrenal tumors
Since the adrenal glands are situated in the retroperitoneum, various vital organs lie in close vicin-
ity. Giant benign adrenal tumors pose challenges for safe surgical resection with preservation of 
vital organs such as kidneys, spleen, mesenteric and great vessels. One such technique is en bloc 
mobilization of the pancreas and spleen for large left adrenal masses derived from multi-visceral 
transplantation techniques [83]. Prompt recognition and management of vascular injury can pre-
vent catastrophe. In a case report of a giant left adrenocortical carcinoma where the superior 
mesenteric artery (SMA) was injured due to anatomical distortion, prompt recognition followed 
by end-to-end anastomosis salvaged the SMA [138]. At times, major vascular resection with the 
placement of a prosthesis may be required. Certain operative principles for giant adrenal tumors 
include a thorough knowledge of retroperitoneal anatomy, careful and meticulous dissection, 
enhanced CT with 3D reconstructions for delineating relationship of the adrenal tumor to the sur-
rounding structures, a low threshold for conversion to open procedure, use of specialized vessel 
sealing devices that can secure small parasitic vessels with minimal collateral thermal damage; 
and adherence to oncologic goals for complete surgical excision to minimize disease recurrence.
6. Conclusion
Knowledge of unusual adrenal masses is essential for those clinicians involved in the man-
agement of adrenal disorders. This chapter has provided a comprehensive review of the 
pathogenesis, clinical presentation, and management of uncommon adrenal masses.
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